Topic List : Health Policy
Nicotine arms race
In this Q&A, Robert Jackler, a professor who has studied the rapid rise of e-cigarettes among youth, discussed the impact of Juul, a high-nicotine vaping device.
Gun injury readmissions cost $86 million a year
A study from Stanford researchers has found that readmissions account for 9.5 percent of the $911 million spent annually on gun-injury hospitalizations.
Gun laws and child gun deaths
States with strict gun laws have lower rates of gun deaths among children and teenagers, and laws to keep guns away from minors are linked with fewer gun suicides in this age group, a Stanford study found.
Grant funds tobacco research
Scientists at Stanford and two other universities have received a five-year, $11.6 million grant to conduct research on policies related to tobacco retail sales.
Rally to raise awareness scheduled
After a statement about guns ended prospects for a government appointment, a Stanford professor joined a student in forming a nonprofit to address the public health issue.
A model for stemming opioid crisis
Increasing the availability of naloxone, cutting opioid prescriptions by 25 percent and expanding drug-treatment programs could reduce opioid-related deaths by 6,000 over 10 years, Stanford researchers estimate.
Zulman on engaging high-need patients
Patient engagement requires creativity, trust building and flexibility from health care providers, especially when treating high-need patients, a new Stanford study says.
Lay worker effective in end-of-life talks
The findings suggest that patients with a serious illness are more at ease with decisions about their care when they discuss their care preferences with someone outside the medical context, according to Stanford researchers.
Symposium addresses electronic health records
The daylong event touched on fixing inefficiencies in EHRs, harnessing data for population health management, building on successes and overcoming obstacles.
Benefits to science vs. privacy concerns
A survey of people who have taken part in clinical trials indicates that participants care more about the benefits to science than the risk of sharing their personal data, researchers at Stanford found.